ANI PHARMACEUTICALS INC. - COMMON STOCK

ANI Pharmaceuticals Announces FDA Approval and Commercial Availability of New 1-mL Vial Size of Purified Cortrophin® Gel, Appropriate for Adjunctive Treatment of Certain Patients with Acute Gouty Arthritis Flares

02 Oct 2023 06:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023

18 Sep 2023 16:05:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Tablets USP

12 Sep 2023 06:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Announces the FDA Approval and Launch of Estradiol Gel, 0.1%

28 Aug 2023 06:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference

24 Aug 2023 06:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Appoints Healthcare Executive Matthew J. Leonard to its Board of Directors

23 Aug 2023 06:50:00 By Nasdaq GlobeNewswire

ANI Pharmaceuticals Reports Record Second Quarter 2023 Financial Results and Raises Full-Year 2023 Guidance  

09 Aug 2023 06:50:31 By Nasdaq GlobeNewswire

ANI Pharmaceuticals to Discuss Second Quarter 2023 Financial Results on August 9, 2023, at 8:30 a.m. ET

31 Jul 2023 07:17:19 By Nasdaq GlobeNewswire